Myasthenia Gravis Presenting after Administration of the mRNA-1273 Vaccine

Myasthenia Gravis Presenting after Administration of the mRNA-1273 Vaccine

The mRNA-1273 SARS-CoV-2 vaccine received emergency use authorization in December 2021. We present a case of myasthenia gravis (MG) which became clinically apparent following vaccination against SARS-CoV-2. A 30-year-old man developed acute onset diplopia, 2 days after receiving his first mRNA-1273...

Full description

Bibliographic Details
Main Authors: Yoji Hoshina, Christopher Sowers, Virginia Baker
Format: Article
Language:English
Published: SMC MEDIA SRL 2022-07-01
Series:European Journal of Case Reports in Internal Medicine
Subjects:
myasthenia gravis
sars-cov-2
mrna-1273
Online Access:https://www.ejcrim.com/index.php/EJCRIM/article/view/3439

Similar Items

Similar Items